ArticleCardio-oncology (London, England)2020

Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin.

Jieli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.